Atreca Lands $56,000,000 Series A Funding Round

  • Feed Type
  • Date
    11/5/2015
  • Company Name
    Atreca
  • Mailing Address
    500 Saginaw Drive 1st Floor Redwood City, CA 94063 USA
  • Company Description
    Atreca is a biotechnology company developing novel therapeutics based on a deep understanding of the human immune response, with lead portfolio programs focused on applications in cancer treatment.
  • Website
    http://www.atreca.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $56,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    This financing will accelerate Atreca’s momentum and advance its pipeline.
  • M&A Terms
  • Venture Investor
    Bill & Melinda Gates Foundation
  • Venture Investor
    Mission Bay Capital
  • Venture Investor
    GlaxoSmithKline